methandrostenolone has been researched along with Liver Neoplasms in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lejolly, JM; Najean, Y; Pecking, A | 1 |
Falk, H; Ishak, KG; Popper, H; Thomas, LB | 1 |
Bombi, J; Bruguera, M; Camacho, L; Hernandez-Nieto, L; Rozman, C | 1 |
Feagler, JR; Hartmann, JR; Johnson, FL; Lerner, KG; Majerus, PW; Siegel, M; Thomas, ED | 1 |
4 other study(ies) available for methandrostenolone and Liver Neoplasms
Article | Year |
---|---|
[Liver toxicity of androgen therapy in aplastic anemia].
Topics: Androgens; Anemia, Aplastic; Humans; Liver; Liver Neoplasms; Long-Term Care; Male; Methandrostenolone; Prospective Studies; Time Factors | 1980 |
Hepatic angiosarcoma associated with androgenic-anabolic steroids.
Topics: Androstanes; Female; Fluoxymesterone; Hemangiosarcoma; Humans; Hypogonadism; Liver; Liver Neoplasms; Male; Menstruation Disturbances; Methandrostenolone; Middle Aged; Multiple Myeloma; Stanozolol; Testosterone | 1979 |
Benign liver-cell adenoma associated with long-term administration of an androgenic-anabolic steroid (methandienone).
Topics: Adult; Carcinoma, Hepatocellular; Hemoglobinuria, Paroxysmal; Humans; Liver Neoplasms; Male; Methandrostenolone | 1977 |
Association of androgenic-anabolic steroid therapy with development of hepatocellular carcinoma.
Topics: Adolescent; Adult; Anabolic Agents; Androgens; Anemia, Aplastic; Carcinoma, Hepatocellular; Child, Preschool; Fanconi Syndrome; Female; Humans; Liver Function Tests; Liver Neoplasms; Male; Methandrostenolone; Methyltestosterone; Oxymetholone; Prednisone; Radionuclide Imaging; Testosterone | 1972 |